Researchers make significant discovery around how inflammation works

April 23, 2018, Queen's University Belfast
Credit: Queen's University Belfast

A research team from Queen's University Belfast, in collaboration with an international team of experts, have made ground-breaking insights into how inflammatory diseases work.

This development could in time lead to new treatments for a range of diseases caused by inflammation, including sepsis, Crohn's disease, psoriasis and Multiple Sclerosis.

The findings have recently been published in the highly prestigious scientific journal, Nature Communications.

The team, led by Professor Paul Moynagh, Professor of Immunology at the Wellcome-Wolfson Institute for Experimental Medicine at Queen's University Belfast alongside Researchers from the Wellcome-Wolfson Institute for Experimental Medicine at Queen's, Dr. Alice Dubois and Dr. Rebecca Ingram found that a protein called Pellino 2 plays an important role in how the body starts the inflammatory response.

Professor Moynagh, explains: "Inflammation is the body's response to infection by disease-causing micro-organisms. This involves the movement of , such as neutrophils, from blood vessels, into the infected tissue where they destroy the invading micro-organism.

"However, the recruitment of neutrophils into tissues needs to be tightly controlled since prolonged tissue infiltration of these cells will lead to damage of normal healthy tissue. In the case of sepsis, we see inflammation spread rapidly throughout the body as a response to a in the blood, which can lead to life-threatening organ dysfunction."

The protein discovered by the researchers is involved in the triggering of the movement of white blood cells called neutrophils from blood vessels into the tissue that is infected by invading micro-organisms. Neutrophils kill the infection, but if they linger for too long they can also damage healthy tissue. If a method can be found to effectively and safely block or control the protein, then it could in future be developed into a specific therapy.

The research team has already had success with stopping the protein in lab-based models and is now exploring molecules that could potentially be turned into a therapy.

Inflammatory diseases are regarded as amongst some of the most difficult to treat, with sepsis in particular posing a critical challenge to frontline health care professionals. Understanding how the body promotes the migration of neutrophils into may provide important clues for designing new drugs to control such as sepsis.

Studies suggest that vulnerability to sepsis is on the rise around the world, as more people undergo invasive procedures or take immunosuppressive drugs to treat other chronic conditions, due to both aging populations and increased access to healthcare. A global rise in resistance to antibiotics also has increased the risk of blood poisoning, driving a growth in sepsis cases.

Dr. Alice Dubois, Researcher at the Wellcome-Wolfson Institute for Experimental Medicine at Queen's, commented on the breakthrough: "Our team at Queen's University demonstrated that the Pellino 2 protein was involved in the production of molecules that promote inflammation during bacterial infection. Blocking this particular protein could therefore be a strategy to treat caused by bacteria. This is a key step forward in improving treatment and patient outcomes in a wide range of diseases.

"Queen's University is committed to tackling global health issues. Inflammatory is prevalent, problematic and difficult to treat; understanding it is one of the most important challenges in medical research today."

Professor Moynagh's team includes Dr. Fiachra Humphries, Dr. Ronan Bergin, Dr. Nezira Delagic; Dr. Bingwei Wang and Ruaidhri Jackson of Maynooth University; and Dr. Shuo Yang of the Nanjing Medical University, China.

Explore further: Scientists discover treatment target for sepsis

Related Stories

Scientists discover treatment target for sepsis

March 14, 2018
In a study published in Nature Communications, Northwestern Medicine scientists demonstrated the key role a molecule called oxPAPC plays in regulating the inflammatory response—findings which could inform the development ...

Scavenging of inflammatory molecules improves sepsis in mice

May 19, 2016
Sepsis is a life-threatening complication of infection in which the molecules that the body releases to fight an infection trigger widespread inflammatory responses, resulting in damage to multiple organ systems.

Blocking inflammation could lead to tailored medical treatments

September 19, 2011
By using a mouse model of inflammation researchers at the University of Calgary have discovered a new class of molecules that can inhibit the recruitment of some white blood cells to sites of inflammation in the body. A provisional ...

Immune study points to new ways to treat lung disease

August 14, 2017
Fresh insight into how the immune system keeps itself in check could lead to new ways of fighting chronic lung disease.

Searching for targeted treatments for inflammatory diseases

February 6, 2018
Inflammatory diseases such as Crohn's disease and multiple sclerosis have been linked to faults in a critical immune pathway that enables inflammation to continue unchecked.

MicroRNA could help treat cancer and asthma

February 15, 2018
A microRNA that regulates inflammation shows promise as a treatment for inflammatory diseases such as asthma and cancer, according to research published in Cell Reports.

Recommended for you

Targeting sepsis, the leading cause of ICU deaths, with a nanocarrier-delivered microRNA

December 3, 2018
One in three patients who die in the U.S. dies of sepsis, according to the Centers for Disease Control and Prevention. It is one of the leading causes of death in intensive care units and, with an estimated price tag of $20 ...

Cells using sugar for metabolic process may fight inflammation

November 27, 2018
New research by a team from the FAMU-FSU College of Engineering has discovered that a type of adult stem cell found in a variety of tissues can be manipulated to enhance tissue regeneration and potentially treat inflammatory ...

To resolve inflammation, location matters

November 19, 2018
Health conditions that involve inflammation run the gamut, from multiple sclerosis and lupus to arthritis, diabetes, and cancer. While inflammation can serve as a normal response to help the body deal with injury or infection, ...

Patchy distribution of joint inflammation resolved

November 16, 2018
Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic, disabling diseases with a poor outcome for loco-motoric function if left untreated. RA and SpA each affect ...

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Can't exercise? A hot bath may help improve inflammation, metabolism, study suggests

November 14, 2018
Hot water treatment may help improve inflammation and blood sugar (glucose) levels in people who are unable to exercise, according to a new study. The findings are published ahead of print in the Journal of Applied Physiology.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.